Dr RR Baliga's "Got Knowledge Doc" Podkast

🫀🧠🛡️ Sense. Signal. Scar.

A striking Cell study reframes myocardial infarction as a systems disease, not a heart-only event. Using single-cell and spatial transcriptomics in murine MI, the authors identify a triple-node heart–brain–immune loop: TRPV1-positive vagal sensory neurons (injury sensing) → hypothalamic paraventricular nucleus AT1aR neurons (central integration) → superior cervical ganglion IL-1β signaling (sympathetic–immune effector arm).

Intervening at any node improved ejection fraction, reduced infarct size, and normalized autonomic balance—pointing to neuroimmune modulation as a new therapeutic frontier beyond myocardium-centric care.

📌 Key takeaway: Treat the circuit, not just the scar.

📖 Yadav et al., Cell (2026)

🦵🌙 Restless Legs Syndrome: more than a sleep complaint

RLS affects ~3% of adults and is frequently missed or misdiagnosed as insomnia or anxiety. The latest evidence underscores three practical shifts: think iron (even when "normal"), choose gabapentinoids first, and beware dopaminergic augmentation.

For internists and frontline clinicians, recognizing RLS early can meaningfully improve sleep, mood, and quality of life—and may even reduce downstream cardiovascular risk. 🧠🩺💤

#RestlessLegsSyndrome #SleepMedicine #InternalMedicine #IronDeficiency #Gabapentinoids #Augmentation #PLMS #ClinicalPractice

🧠🩺 Why cancers behave the way they do—and why treatments fail

For internists, cancer is not just an oncologic diagnosis but a systems disease: driven by dysregulated growth, immune evasion, metabolic reprogramming, inflammation, and adaptive resistance.

The Hallmarks of Cancer framework offers a unifying clinical lens—explaining recurrence, cachexia, immunotherapy variability, and late relapse—without drowning us in molecular minutiae.

Understanding how tumors survive stress, therapy, and time sharpens prognosis, improves cross-disciplinary care, and strengthens bedside reasoning.

🔬 From biology to bedside. 🧩 From mechanisms to meaning. 📈 From treatment to trajectory.

📟🪑🏃‍♂️ A striking accelerometer-based analysis in The Lancet suggests that small, realistic behavior shifts could translate into meaningful mortality gains at the population level. For the least active adults, +5 minutes/day of moderate-to-vigorous physical activity (MVPA) was associated with preventing ~6% of deaths; applying a similar increase broadly (excluding the most active) could prevent ~10%. Reducing sedentary time by 30 minutes/day was associated with preventing ~3% (high-risk) to ~7% (population) of deaths (with smaller—but still meaningful—effects in UK Biobank).

🎯 Practical takeaway: "5 minutes more exercise, 30 minutes less sitting." Small hinges, big doors.

(Ekelund et al., The Lancet, 2026)

🦵❤️ Peripheral Artery Disease is not just a leg problem—it's a life-threatening cardiovascular signal.

Up to 60% of patients are asymptomatic, yet PAD doubles to triples the risk of myocardial infarction, stroke, and death. Evidence is clear: exercise therapy, statins, antiplatelet or rivaroxaban-based strategies, blood-pressure control, and GLP-1/SGLT2 therapies save limbs and lives.

🚶‍♂️💊🫀 When walking hurts—or quietly fades—cardiovascular risk rises. PAD deserves the same urgency as coronary disease.

#PeripheralArteryDisease #PreventiveCardiology #Claudication #ExerciseMedicine #Atherosclerosis #CardioVascularRisk

🫀 What do the 2026 AHA Statistics really tell us?

The latest AHA update makes one message unmistakably clear: prevention works—but only when systems work. From Life's Essential 8 🧭 to the rise of cardiovascular–kidney–metabolic (CKM) health 🩺🧪, the data show that blood pressure control, sleep 😴, physical activity 🚶‍♂️, nutrition 🥗, and nicotine cessation 🚭 shape not only heart outcomes, but brain health 🧠, equity ⚖️, and healthcare costs 💰.

The challenge ahead isn't discovering new risk factors—it's implementing what we already know, at scale and with fairness. Prevention is no longer aspirational; it's clinical, economic, and moral necessity.

Sri Ramakrishna Paramahamsa showed that spiritual truth is lived, not debated 🌼🙏

Through devotion, deep experience, and simple parables, he taught that all religions are different paths to the same Reality 🛤️✨

His enduring message—serve humanity as the Divine—continues to inspire seekers, caregivers, and leaders alike ❤️🌍

CRT—now framed as cardiac physiologic pacing—remains a cornerstone for HFrEF patients with LVEF ≤50% and either high ventricular pacing burden or a wide QRS, with the biggest gains in LBBB and QRS ≥150 ms. ⚡🫀📈

Traditional biventricular pacing has randomized-trial evidence (>10,000 patients) showing better symptoms, quality of life, remodeling, fewer HF hospitalizations, and survival benefit in selected groups; meanwhile His bundle and left bundle branch pacing are rapidly expanding options, with large randomized trials underway to define comparative efficacy and safety. 🧠🔧🔬

🩺 Hypertension control in the U.S. has stalled—despite better meds, better evidence, and better tools. 📉 The "paradox" isn't a mystery so much as a systems problem: therapeutic inertia, fragmented care, cost barriers, and inconsistent use of validated home BP monitoring. 🧩

What works is boring (and therefore powerful): standardized treatment protocols, team-based care, rapid follow-up, combination therapy when appropriate, and performance feedback loops. 🧰📊

If we treat BP control like a reliable system—rather than a heroic, one-visit effort—we can move the curve again. 🎯❤️ #Hypertension #PrimaryCare #Cardiology #QualityImprovement #PopulationHealth

🧬 Why does cancer mostly strike later in life? This review frames an elegant answer: evolution built layered anti-cancer "barriers" optimized to protect us through reproductive years—not indefinitely. 🛡️

With aging, those safeguards fray: tissues remodel, epigenetic "noise" rises, inflammation smolders, and immune surveillance softens—so clones that were once contained can progress. 🕰️🔥

A favorite reminder is 🐘 Peto's paradox: bigger, longer-lived species aren't overwhelmed by cancer, suggesting nature can evolve stronger defenses when fitness demands it.

Takeaway: late-life cancer risk isn't just "more mutations"—it's changing context + weakening constraints. ✅